Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions
Author:
- 30 November 2018
- journal article
- research article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2018 (1) , 339-347
Abstract
Oral anticoagulants are commonly prescribed but high risk to cause adverse events. Skilled drug interaction management is essential to ensure safe and effective use of these therapies. Clinically relevant interactions with warfarin include drugs that modify cytochrome 2C9, 3A4, or both. Drugs that modify p-glycoprotein may interact with all direct oral anticoagulants, and modifiers of cytochrome 3A4 may interact with rivaroxaban and apixaban. Antiplatelet agents, nonsteroidal anti-inflammatory drugs, and serotonergic agents, such as selective serotonin reuptake inhibitors, can increase risk of bleeding when combined with any oral anticoagulant, and concomitant use should be routinely assessed. New data on anticoagulant drug interactions are available almost daily, and therefore, it is vital that clinicians regularly search interaction databases and the literature for updated management strategies. Skilled drug interaction management will improve outcomes and prevent adverse events in patients taking oral anticoagulants.Keywords
This publication has 82 references indexed in Scilit:
- Importance of Pharmacokinetic Profile and Variability as Determinants of Dose and Response to Dabigatran, Rivaroxaban, and ApixabanCanadian Journal of Cardiology, 2013
- Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literatureBMC Pharmacology and Toxicology, 2013
- Oral Anticoagulant TherapyChest, 2012
- Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trialJournal of Thrombosis and Haemostasis, 2011
- Bleeding Incidence With Concomitant Use of Antidepressants and WarfarinTherapeutic Drug Monitoring, 2011
- Warfarin Potentiation: A Review of the “FAB-4” Significant Drug InteractionsThe Consultant Pharmacist, 2009
- Warfarin With Fluoroquinolones, Sulfonamides, or Azole Antifungals: Interactions and the Risk of Hospitalization for Gastrointestinal BleedingClinical Pharmacology & Therapeutics, 2008
- Intracerebral hemorrhage secondary to a warfarin-metronidazole interactionThe American Journal of Geriatric Pharmacotherapy, 2008
- Single-Dose Fluconazole for Vulvovaginal CandidiasisObstetrics & Gynecology, 2006
- Voriconazole potentiates warfarin‐induced prothrombin time prolongationBritish Journal of Clinical Pharmacology, 2003